Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute